Efficiency of arterial hypertension risk assessment using digital technologies in production

The analysis of the efficiency of СAP ESMO manufactured by KVAZAR LLC, Russia, use was carried out based on the PMN database for 7 years (2016‑2023). A decrease in the MLC values by 4.7 times, a decrease in cases of excess systolic blood pressure >140 mm Hg by 2.25 times, a decrease in the number of workers with hypertension by 22.9% were revealed. The introduction of the KAP ESMO objectifies the assessment of the health status of workers and improves the routing of patients with blood pressure deviations, which is important for improving of pre-shift medical examinations and the efficiency of hypertension risk assessment.